MYO News and Press, Myomo Inc. From 09/28/21

BOSTON, MA / ACCESSWIRE / September 28, 2021 / Myomo, Inc. (NYSE American:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, Myom...

Myomo Inc. is a commercial stage medical robotics company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis. The company develops and markets the MyoPro product line, which is steadily gaining traction with rising year-over-year sal...

Patents Expected to be Licensed to Newly Established Joint Venture Company in China Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from n...

Myomo, Inc. (NYSE American:MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, Myomo’s...

2Q:22 Results Exceed Our Estimates As Revenue Triples Myomo (NYSE American: MYO) was featured in a company-sponsored research earnings release note published by Sidoti & Company, LLC. The report reads, “There are now more 898 units waiting for reimbursement approval, compare...

Gainers: Fulcrum Therapeutics (NASDAQ:FULC) +84%, Allied Healthcare Products (NASDAQ:AHPI) +39%, IMV (NASDAQ:IMV) +29%, Exagen (NASDAQ:XGN) +26%, Myomo (NYSE:MYO) +22%. Losers: SmileDirectClub (NASDAQ:SDC) -23%, EyeGate Pharmaceutica...

Myomo, Inc. (MYO) Q2 2021 Earnings Conference Call August 9, 2021 4:30 PM ET Company Participants Kim Golodetz – LHA Investor Relations Paul Gudonis – Chief Executive Officer Dave Henry – Chief Financial Officer Conference Call Participants Scott Henry – ROTH Capit...

Revenue was $3.1 million, up 262% over prior year Gross margin was 71%, up 2,000 basis points over prior year Insurance authorizations and orders were a record 138 Conference call begins at 4:30 p.m. Eastern time today Myomo, Inc. (NYSE American: MY...

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial re...

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that the Healthcare Quality Asso...